Investing.com -- GSK plc (LON: GSK ), a U.K.-based pharmaceutical company, said on Monday that its Blenrep combinations have been approved by Japan’s Ministry of Health. This approval is for the ...

The pharma company said it expects more approvals through the year following positive results from a Phase 3 trial.

Children with asthma experienced fewer exacerbations and better control with dupilumab regardless of the duration of their ...

Some Indonesian netizens oppose the clinical trial of a tuberculosis (TB) vaccine candidate in Indonesia, whose development ...